Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Republicans were convinced to vote for Trump budget with autographs and pics
3/07/2025
GOP lawmaker caught dumping Medicaid provider stock before megabill vote
3/07/2025
Vladimir Putin tells Trump : 'Russia will not back down' on Ukraine goals
3/07/2025
Trump contradicted as Feds tell judge Alligator Alcatraz nothing to do with them
3/07/2025
Trump wanted MAGA conspiracy theorist over Karoline Leavitt to do press : report
3/07/2025
'Gabbard provides no proof :' Fight erupts between Tulsi and WaPo reporter
3/07/2025